
Robin Garner Initiated (XERS) at Strong Buy and Held Target at $4.5 on, Aug 28th, 2023
Robin Garner of Craig-Hallum, Initiated "Xeris Biopharma Holdings, Inc." (XERS) at Strong Buy and Held Target at $4.5 on, Aug 28th, 2023.
Robin has made no other calls on XERS in the last 4 months.
There is 1 other peer that has a rating on XERS. Out of the 1 peers that are also analyzing XERS, 0 agree with Robin's Rating of Hold.
This is the rating of the analyst that currently disagrees with Robin
- Oren Livnat of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $6 on, Wednesday, August 9th, 2023
Contributing Sources